Finance

Lists
Outlook: 23.1% bullish·7.7% bearish
Go to analysis
AJG:NYSE
Arthur J. Gallagher & Co.
$232.70
-0.58%
(-1.35) 1D
$232.47
-0.10% (-0.23)
After hours
Closed: Oct 9, 4:00:46 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AJG...
Open
$233.74
High
$235.94
Low
$231.50
Mkt. cap
59.64B
Avg. vol.
1.46M
Volume
960.85K
Dividend
1.20%
Quarterly dividend
$0.70
Ex-dividend date
Sep 8, 2026
P/E ratio
38.47
52-wk high
$305.74
52-wk low
$190.75
EPS
$6.05
Beta
0.55
Shares outstanding
256.30M
No. of employees
67K
Open
$233.74
High
$235.94
Low
$231.50
Mkt. cap
59.64B
Avg. vol.
1.46M
Volume
960.85K
Dividend
1.20%
Quarterly dividend
$0.70
Ex-dividend date
Sep 8, 2026
P/E ratio
38.47
52-wk high
$305.74
52-wk low
$190.75
EPS
$6.05
Beta
0.55
Shares outstanding
256.30M
No. of employees
67K
News stories
From web sources and news partners
Profile
Arthur J. Gallagher & Co. is an American insurance brokerage and risk management services company based in Rolling Meadows, Illinois, a suburb of Chicago. The company provides insurance brokerage services and risk management services, the latter of which primarily includes the processing of workers compensation and automobile insurance claims through the company's adjusters. The company is ranked 367th on the Fortune 500 and 192nd on the Forbes Global 2000. Founded in 1927, the company ranks among the world's largest insurance brokers. Wikipedia
About Arthur J. Gallagher & Co.
CEOJ. Patrick Gallagher Jr
Employees67.5K
Founded1927
HeadquartersRolling Meadows, Illinois, United States
SectorInsurance
Websiteajg.com
Analyst ratings
Based on 16 analysts giving stock ratings to AJG in the past 3 months
Strong buy
Buy
12
Hold
4
Sell
0
12-month forecast
Based on 16 Wall Street analysts offering 12 month price targets for AJG in the last 3 months.
Highest
Current $232.70
$307.00 (+31.93%)
Average
$283.57 (+21.86%)
Lowest
$260.00 (+11.73%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Phillips CFA
Oppenheimer
Hold
Initiated
-
-
10/07/2026
Ryan Tunis
Cantor Fitzgerald
Hold
Maintained
$280.00
+20.3%
10/07/2026
Yaron Kinar
Mizuho Securities
Buy
Maintained
$271.00
+16.5%
10/07/2026
Alex Scott
Barclays
Buy
Maintained
$292.00
+25.5%
10/07/2026
Bob Huang
Morgan Stanley
Buy
Maintained
$260.00
+11.7%
10/06/2026
Brian Meredith
UBS
Buy
Reiterated
$299.00
+28.5%
09/25/2026
David Motemaden
Evercore ISI
Buy
Maintained
$307.00
+31.9%
09/24/2026
Robert Cox CFA
Goldman Sachs
Buy
Maintained
$272.00
+16.9%
09/23/2026
Paul Newsome
Piper Sandler
Buy
Maintained
$287.00
+23.3%
09/24/2026
Elyse Greenspan
Wells Fargo
Buy
Reiterated
$291.00
+25.1%
09/23/2026
Rowland Mayor
RBC Capital
Buy
Maintained
$290.00
+24.6%
09/23/2026
Mark Hughes
Truist Financial
Hold
Reiterated
$265.00
+13.9%
09/24/2026
Kevin Heal
Argus Research
Buy
Maintained
$300.00
+28.9%
08/14/2026
Matthew Heimermann
Citi
Buy
Maintained
$285.00
+22.5%
08/04/2026
Adam Klauber
William Blair
Buy
Maintained
-
-
07/31/2026
Meyer Shields
KBW
Hold
Maintained
$271.00
+16.5%
07/31/2026
Gregory Peters
Raymond James
Hold
Maintained
-
-
06/18/2026
Andrew Andersen
Jefferies
Buy
Reiterated
$265.00
+13.9%
06/18/2026
Michael Zaremski
BMO Capital
Buy
Reiterated
$265.00
+13.9%
06/18/2026
Andrew Kligerman
TD Cowen
Buy
Reiterated
$388.00
+66.7%
06/18/2026
Unknown Analyst
TD Cowen
Buy
Reiterated
$388.00
+66.7%
03/18/2026
Cave Montazeri
Deutsche Bank
Buy
Maintained
$280.00
+20.3%
02/26/2026
Unknown Analyst
Jefferies
Hold
Maintained
$280.00
+20.3%
02/02/2026
Tracy Benguigui
Wolfe Research
Buy
Reiterated
$289.00
+24.2%
01/29/2026
Last report
Jul 30, 2026
Fiscal period
Q2 2026
$2.84 / $2.81
+0.94%beat
Revenue / Est. (USD)
3.86B / 4.04B
-4.55%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
3.16B
3.46B
4.63B
3.86B
Cost of goods sold
1.83B
2.18B
2.40B
2.17B
Cost of revenue
1.83B
2.18B
2.40B
2.17B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
512.50M
580.30M
579.00M
607.00M
Operating expense
786.40M
918.80M
917.00M
944.00M
Total operating expenses
2.61B
3.10B
3.32B
3.12B
Operating income
543.60M
361.60M
1.32B
739.00M
Other non operating income
-
-
-
-
EBT including unusual items
346.90M
180.00M
1.04B
414.00M
EBT excluding unusual items
549.90M
322.20M
1.24B
669.00M
Income tax expense
73.30M
25.70M
220.00M
90.00M
Effective tax rate
21.13%
14.28%
21.09%
21.74%
Other operating expenses
-
-
-
-
Net income
272.70M
151.10M
822.00M
324.00M
Net profit margin
8.63%
4.36%
17.75%
8.40%
Earnings per share
2.32
2.38
4.47
2.84
Interest and investment income
167.10M
121.80M
86.00M
98.00M
Interest expense
-160.80M
-161.20M
-158.00M
-168.00M
Net interest expenses
6.30M
-39.40M
-72.00M
-70.00M
Depreciation and amortization charges
54.10M
58.10M
61.00M
57.00M
EBITDA
817.50M
700.10M
1.65B
1.08B
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps